Average Co-Inventor Count = 15.90
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (11 from 378 patents)
2. Bayer Aktiengesellschaft (7 from 12,160 patents)
3. The Broad Institute, Inc. (7 from 443 patents)
4. Other (1 from 832,843 patents)
5. Dana-farber-cancer Institute Inc. (1 from 1,209 patents)
6. Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (119 patents)
13 patents:
1. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
2. 12152041 - Macrocyclic fluorine substituted indole derivatives
3. 11891404 - Substituted macrocyclic indole derivatives
4. 11478451 - Macrocyclic chlorine substituted indole derivatives
5. 11447504 - Macrocyclic chlorine substituted indole derivatives
6. 11440923 - Substituted macrocyclic indole derivatives
7. 11401278 - Macrocyclic indole derivatives
8. 11286263 - Macrocyclic fluorine substituted indole derivatives
9. 10442772 - Benzimidazol-2-amines as mIDH1 inhibitors
10. 10137110 - 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors
11. 9957235 - Benzimidazol-2-amines as mIDH1 inhibitors
12. 9951027 - Benzimidazol-2-amines as MIDH1 inhibitors
13. 9708311 - Benzimidazole derivatives as EP4 antagonists